LOS ANGELES, Aug. 2, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS). Class Period: May 3, 2023…